alexa Seroprevalence Of Hepatitis B Among HIV Infected Patients Attending Specialist Hospital Sokoto, Nigeria
ISSN: 2161-0703

Journal of Medical Microbiology & Diagnosis
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

June 21-23, 2017 London, UK

Aliyu B, Danlami M B, Manga S B and Muh’d U K
Federal University, Nigeria
Usmanu Danfodiyo University, Nigeria
Posters & Accepted Abstracts: J Med Microb Diagn
DOI: 10.4172/2161-0703-C1-006
Hepatitis B virus (HBV) is of public health importance globally. Viral hepatitis, especially B forms a considerable percentage of liver disease worldwide. This study aims to determine the seroprevalence of hepatitis B virus among HIV infected patients attending Sokoto Specialist Hospital with a view to establish prevalence rate in the state. Serum samples were collected from HIV infected patients, and analyzed to determine the presence of hepatitis B surface antigen (HBsAg) using Biorex ELISA kit (HBV). Out of 140 HIV patients tested for hepatitis B surface antigen (HBsAg) only 19 individuals were found positive given the prevalence rate of 13.6% (19/140) among HIV patients. The statistical analysis has shown that there was no observable statistical significant difference between demographic data, clinical characteristics and risk factors with respect to HBV infection. Two of the 140 HIV patients were in the chronic stage of the infection giving a prevalence of 1.43% and two of the patients were at the acute stage of the infection with a percentage prevalence of 1.43% while the remaining 15 patients were in the active stage of the infection. There was no statistically significant relationship between the mean CD4 counts (428 cells/μl of blood) in HIV mono-infected patients and the mean CD4 counts (391.1579 cells/μl of blood) in HBV/HIV co-infected individuals (t=22.1351, df=1, p-value=0.02874, 95% confidence interval: 174.435–644.5648, mean=409.5). Therefore, HIV patients should be screened for HBV during their clinical visit in order to inform clinical management, also adequate care and support programs should be organized to help people living with both infections.

Email: [email protected]

image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version